US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NanoViricides

0.8800

+0.03003.53%

Post-market: 0.94000.0600+6.82%19:47 EST

Volume:250.96K

Turnover:225.83K

Market Cap:18.98M

PE:-1.73

High:0.9300

Open:0.8910

Low:0.8800

Close:0.8500

52wk High:2.23

52wk Low:0.8500

Shares:21.57M

Float Shares:20.97M

Volume Ratio:0.94

T/O Rate:1.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5092

EPS(LYR):-0.6263

ROE:-94.03%

ROA:-51.13%

PB:2.65

PE(LYR):-1.41

Loading ...

Overview Company News Filings

NanoViricides President Unveils Breakthrough Antiviral Technology in Mission Matters Interview

NanoViricides Inc. to Present at DealFlow Discovery Conference in Atlantic City

NanoViricides Reports NV-387 Outperforms Tamiflu and Xofluza Against H3N2 in Animal Studies

NanoViricides Inc (Pre-Reincorporation) : Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $6

THOMSON REUTERS

BRIEF-anoViricides Signs Agreement for Orphan Drug Strategy of NV-387 for Mpox, Smallpox, and Measles

NanoViricides: Signed Master Services Agreement With Only Orphans Cote for Orphan Drug Strategy of Nv-387 for Treatment of Mpox, Smallpox, & Measles

THOMSON REUTERS

NanoViricides Signs Master Services Agreement with Only Orphans Cote for Orphan Drug Strategy

NanoViricides Holds 2025 Annual Stockholders Meeting

NanoViricides Inc. Held Annual Shareholder Meeting

NanoViricides reports Q3 EPS (10c) vs. (23c) last year

NanoViricides Secures $6 Million Through Securities Offering

NanoViricides Launches Private Placement of Warrants in $6 Million Funding Deal

NanoViricides Presents Drug Pipeline at Pharma Partnering Summit 2025

NanoViricides prices 3.57M shares at $1.68 in registered direct offering

NanoViricides Inc. Launches Private Placement of Warrants in $6 Million Deal

NanoViricides receives approval to start Phase II trial of NV-387

NanoViricides Wins DRC Approval to Begin Phase II Trial of NV-387 for MPox

NanoViricides Inc. to Present at Spartan Capital Investor Conference in New York City

NanoViricides Announces NV-387 Shows Potent Anti-Measles Activity in Phase I Trial

NanoViricides Reports Strong Antiviral Activity for NV-387 Against Measles in Preclinical Studies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NNVC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NNVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NNVC\",,,,,undefined,":{"symbol":"NNVC","market":"US","secType":"STK","nameCN":"NanoViricides","latestPrice":0.88,"timestamp":1770411600000,"preClose":0.85,"halted":0,"volume":250963,"hourTrading":{"tag":"盘后","latestPrice":0.94,"preClose":0.88,"latestTime":"19:47 EST","volume":7312,"amount":6778.377,"timestamp":1770425261333,"change":0.06,"changeRate":0.068182,"amplitude":0.068182},"delay":0,"changeRate":0.03529411764705886,"floatShares":20968000,"shares":21568400,"eps":-0.509157,"marketStatus":"Market Closed","change":0.03,"latestTime":"02-06 16:00:00 EST","open":0.891,"high":0.93,"low":0.88,"amount":225830.51113539998,"amplitude":0.058824,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.509157,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1380081600000,"exchange":"AMEX","adjPreClose":0.85,"preHourTrading":{"tag":"盘前","latestPrice":0.931,"preClose":0.85,"latestTime":"08:56 EST","volume":2260,"amount":2121.5100024,"timestamp":1770386212748,"change":0.081,"changeRate":0.095294,"amplitude":0.058706},"postHourTrading":{"tag":"盘后","latestPrice":0.94,"preClose":0.88,"latestTime":"19:47 EST","volume":7312,"amount":6778.377,"timestamp":1770425261333,"change":0.06,"changeRate":0.068182,"amplitude":0.068182},"volumeRatio":0.9422690628636481,"impliedVol":0.1549,"impliedVolPercentile":0.1912},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NNVC\",,,,,undefined,":{"symbol":"NNVC","floatShares":20968000,"roa":"-51.13%","roe":"-94.03%","lyrEps":-0.626265,"volumeRatio":0.9422690628636481,"shares":21568400,"dividePrice":0,"high":0.93,"amplitude":0.058824,"preClose":0.85,"low":0.88,"week52Low":0.85,"pbRate":"2.65","week52High":2.2299,"institutionHeld":0,"latestPrice":0.88,"eps":-0.509157,"divideRate":0,"volume":250963,"delay":0,"ttmEps":-0.509157,"open":0.891,"prevYearClose":1.13,"prevWeekClose":0.965,"prevMonthClose":0.965,"prevQuarterClose":1.13,"fiveDayClose":0.965,"twentyDayClose":1.21,"sixtyDayClose":1.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NNVC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-09-29","symbol":"NNVC","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-05-15","symbol":"NNVC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-02-14","symbol":"NNVC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-11-14","symbol":"NNVC","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-09-27","symbol":"NNVC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1727409600000,"reportTimeType":"post","actualEps":-0.19}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NNVC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NNVC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1765947600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NNVC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NNVC","date":"2026-02-06","current":-1.728347,"percent":0.634267,"low":-8.257983,"twenty":-3.241125,"median":-2.403874,"eighty":-2.020561,"high":-1.333135,"avg":-2.81853,"sd":1.251118,"marketCap":18333164},"quantilePoints":[{"date":"2021-02-12","current":-3.78622,"twenty":-11.341292,"median":-5.07155,"eighty":-2.519791,"marketCap":53751600},{"date":"2021-02-19","current":-3.620149,"twenty":-11.311529,"median":-5.024525,"eighty":-2.519791,"marketCap":52851150},{"date":"2021-02-26","current":-3.057014,"twenty":-11.271284,"median":-5.00388,"eighty":-2.519791,"marketCap":44629860},{"date":"2021-03-05","current":-3.876119,"twenty":-11.177066,"median":-4.973773,"eighty":-2.518657,"marketCap":56588100},{"date":"2021-03-12","current":-3.817611,"twenty":-11.075262,"median":-4.952574,"eighty":-2.518657,"marketCap":55733940},{"date":"2021-03-19","current":-3.678656,"twenty":-10.947439,"median":-4.928766,"eighty":-2.518657,"marketCap":53705310},{"date":"2021-03-26","current":-3.605522,"twenty":-10.921244,"median":-4.89353,"eighty":-2.519791,"marketCap":52637610},{"date":"2021-04-01","current":-3.47388,"twenty":-10.851236,"median":-4.872521,"eighty":-2.519791,"marketCap":50715750},{"date":"2021-04-09","current":-3.408059,"twenty":-10.781228,"median":-4.831249,"eighty":-2.518657,"marketCap":49754820},{"date":"2021-04-16","current":-3.00582,"twenty":-10.596948,"median":-4.785979,"eighty":-2.518657,"marketCap":43882470},{"date":"2021-04-23","current":-3.057014,"twenty":-10.508695,"median":-4.726099,"eighty":-2.518657,"marketCap":44629860},{"date":"2021-04-30","current":-3.035074,"twenty":-10.404778,"median":-4.666105,"eighty":-2.518657,"marketCap":44309550},{"date":"2021-05-07","current":-2.654776,"twenty":-9.700722,"median":-4.544321,"eighty":-2.518657,"marketCap":38757510},{"date":"2021-05-14","current":-4.562569,"twenty":-9.419194,"median":-4.510132,"eighty":-2.506117,"marketCap":39347100},{"date":"2021-05-21","current":-4.776022,"twenty":-9.231528,"median":-4.510132,"eighty":-2.506117,"marketCap":41187900},{"date":"2021-05-28","current":-4.789363,"twenty":-9.074029,"median":-4.510132,"eighty":-2.506117,"marketCap":41302950},{"date":"2021-06-04","current":-5.002817,"twenty":-9.026854,"median":-4.518582,"eighty":-2.509122,"marketCap":43143750},{"date":"2021-06-11","current":-5.883312,"twenty":-8.963729,"median":-4.518582,"eighty":-2.509122,"marketCap":50737050},{"date":"2021-06-18","current":-5.082862,"twenty":-8.899973,"median":-4.518582,"eighty":-2.509122,"marketCap":43834050},{"date":"2021-06-25","current":-6.216833,"twenty":-8.83748,"median":-4.518582,"eighty":-2.509122,"marketCap":53613300},{"date":"2021-07-02","current":-5.736563,"twenty":-8.774355,"median":-4.518582,"eighty":-2.509122,"marketCap":49471500},{"date":"2021-07-09","current":-5.576473,"twenty":-8.71123,"median":-4.518582,"eighty":-2.509122,"marketCap":48090900},{"date":"2021-07-16","current":-5.242952,"twenty":-8.71123,"median":-4.518582,"eighty":-2.509122,"marketCap":45214650},{"date":"2021-07-23","current":-5.656518,"twenty":-8.672078,"median":-4.518582,"eighty":-2.509122,"marketCap":48781200},{"date":"2021-07-30","current":-5.363019,"twenty":-8.648105,"median":-4.518582,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-08-06","current":-5.21627,"twenty":-8.605807,"median":-4.518582,"eighty":-2.509122,"marketCap":44984550},{"date":"2021-08-13","current":-5.069521,"twenty":-8.58498,"median":-4.518582,"eighty":-2.509122,"marketCap":43719000},{"date":"2021-08-20","current":-4.949453,"twenty":-8.521855,"median":-4.518582,"eighty":-2.509122,"marketCap":42683550},{"date":"2021-08-27","current":-5.136225,"twenty":-8.381184,"median":-4.527033,"eighty":-2.509122,"marketCap":44294250},{"date":"2021-09-03","current":-5.363019,"twenty":-8.332481,"median":-4.527335,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-09-10","current":-5.256293,"twenty":-8.269356,"median":-4.527335,"eighty":-2.509122,"marketCap":45329700},{"date":"2021-09-17","current":-5.363019,"twenty":-8.206231,"median":-4.527335,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-09-24","current":-6.777149,"twenty":-8.180981,"median":-4.527335,"eighty":-2.509122,"marketCap":58445400},{"date":"2021-10-01","current":-5.869971,"twenty":-8.079981,"median":-4.527335,"eighty":-2.509122,"marketCap":50622000},{"date":"2021-10-08","current":-5.829949,"twenty":-8.016857,"median":-4.527335,"eighty":-2.509122,"marketCap":50276850},{"date":"2021-10-15","current":-6.36953,"twenty":-8.010675,"median":-4.527335,"eighty":-2.509122,"marketCap":56193200},{"date":"2021-10-22","current":-6.304269,"twenty":-7.953732,"median":-4.527335,"eighty":-2.509122,"marketCap":55617450},{"date":"2021-10-29","current":-6.186798,"twenty":-7.94329,"median":-4.527335,"eighty":-2.509122,"marketCap":54581100},{"date":"2021-11-05","current":-6.173746,"twenty":-7.890607,"median":-4.527335,"eighty":-2.509122,"marketCap":54465950},{"date":"2021-11-12","current":-6.095432,"twenty":-7.788302,"median":-4.527335,"eighty":-2.509122,"marketCap":53775050},{"date":"2021-11-19","current":-5.797853,"twenty":-7.663997,"median":-4.527335,"eighty":-2.509122,"marketCap":52899750},{"date":"2021-11-26","current":-6.138903,"twenty":-7.585674,"median":-4.527335,"eighty":-2.509122,"marketCap":56011500},{"date":"2021-12-03","current":-5.633644,"twenty":-7.428051,"median":-4.527335,"eighty":-2.509122,"marketCap":51401500},{"date":"2021-12-10","current":-5.406277,"twenty":-7.300703,"median":-4.527335,"eighty":-2.509122,"marketCap":49327000},{"date":"2021-12-17","current":-5.229436,"twenty":-7.180968,"median":-4.527335,"eighty":-2.509122,"marketCap":47713500},{"date":"2021-12-23","current":-4.976806,"twenty":-7.079181,"median":-4.527335,"eighty":-2.509122,"marketCap":45408500},{"date":"2021-12-31","current":-4.698914,"twenty":-6.987904,"median":-4.527335,"eighty":-2.509122,"marketCap":42873000},{"date":"2022-01-07","current":-3.890498,"twenty":-6.926651,"median":-4.436412,"eighty":-2.509122,"marketCap":35497000},{"date":"2022-01-14","current":-3.675763,"twenty":-6.89782,"median":-4.401483,"eighty":-2.509122,"marketCap":33537750},{"date":"2022-01-21","current":-2.905242,"twenty":-6.846702,"median":-4.310739,"eighty":-2.509122,"marketCap":26507500},{"date":"2022-01-28","current":-2.728401,"twenty":-6.779582,"median":-4.173405,"eighty":-2.509122,"marketCap":24894000},{"date":"2022-02-04","current":-3.05682,"twenty":-6.712109,"median":-4.02803,"eighty":-2.509122,"marketCap":27890500},{"date":"2022-02-11","current":-2.854716,"twenty":-6.637806,"median":-3.995999,"eighty":-2.509122,"marketCap":26046500},{"date":"2022-02-18","current":-2.62043,"twenty":-6.580578,"median":-3.946834,"eighty":-2.509122,"marketCap":22837320},{"date":"2022-02-25","current":-2.646899,"twenty":-6.52606,"median":-3.923893,"eighty":-2.509122,"marketCap":23068000},{"date":"2022-03-04","current":-2.50132,"twenty":-6.496806,"median":-3.868397,"eighty":-2.507562,"marketCap":21799260},{"date":"2022-03-11","current":-2.448382,"twenty":-6.462701,"median":-3.821268,"eighty":-2.492597,"marketCap":21337900},{"date":"2022-03-18","current":-2.964527,"twenty":-6.435992,"median":-3.787617,"eighty":-2.484025,"marketCap":25836160},{"date":"2022-03-25","current":-3.096872,"twenty":-6.399341,"median":-3.766488,"eighty":-2.484025,"marketCap":26989560},{"date":"2022-04-01","current":-2.73954,"twenty":-6.395635,"median":-3.735019,"eighty":-2.484025,"marketCap":23875380},{"date":"2022-04-08","current":-2.593961,"twenty":-6.356646,"median":-3.703835,"eighty":-2.484025,"marketCap":22606640},{"date":"2022-04-14","current":-2.501584,"twenty":-6.335311,"median":-3.656716,"eighty":-2.482663,"marketCap":21801566},{"date":"2022-04-22","current":-2.223395,"twenty":-6.304269,"median":-3.638432,"eighty":-2.478152,"marketCap":19377120},{"date":"2022-04-29","current":-1.97194,"twenty":-6.279718,"median":-3.579246,"eighty":-2.47116,"marketCap":17185660},{"date":"2022-05-06","current":-1.97194,"twenty":-6.219501,"median":-3.523708,"eighty":-2.460477,"marketCap":17185660},{"date":"2022-05-13","current":-1.710426,"twenty":-6.176384,"median":-3.477537,"eighty":-2.45259,"marketCap":14906541},{"date":"2022-05-20","current":-3.57635,"twenty":-6.112925,"median":-3.448283,"eighty":-2.44683,"marketCap":30040400},{"date":"2022-05-27","current":-2.957366,"twenty":-6.0948,"median":-3.404402,"eighty":-2.44683,"marketCap":24841100},{"date":"2022-06-03","current":-2.751038,"twenty":-6.063146,"median":-3.382022,"eighty":-2.44683,"marketCap":23108000},{"date":"2022-06-10","current":-2.778549,"twenty":-6.021887,"median":-3.36235,"eighty":-2.44683,"marketCap":23339080},{"date":"2022-06-17","current":-2.764793,"twenty":-5.978029,"median":-3.327968,"eighty":-2.44683,"marketCap":23223540},{"date":"2022-06-24","current":-2.806059,"twenty":-5.953332,"median":-3.30945,"eighty":-2.445278,"marketCap":23570160},{"date":"2022-07-01","current":-2.599731,"twenty":-5.898451,"median":-3.23985,"eighty":-2.445278,"marketCap":21837060},{"date":"2022-07-08","current":-3.148563,"twenty":-5.871439,"median":-3.219656,"eighty":-2.445278,"marketCap":26447106},{"date":"2022-07-15","current":-2.737283,"twenty":-5.837732,"median":-3.192745,"eighty":-2.445278,"marketCap":22992460},{"date":"2022-07-22","current":-2.874835,"twenty":-5.807263,"median":-3.167389,"eighty":-2.445278,"marketCap":24147860},{"date":"2022-07-29","current":-2.503445,"twenty":-5.78537,"median":-3.144776,"eighty":-2.440257,"marketCap":21028280},{"date":"2022-08-05","current":-4.869338,"twenty":-5.744619,"median":-3.132647,"eighty":-2.440257,"marketCap":40901160},{"date":"2022-08-12","current":-3.823943,"twenty":-5.727928,"median":-3.132647,"eighty":-2.440257,"marketCap":32120120},{"date":"2022-08-19","current":-3.342511,"twenty":-5.684312,"median":-3.132647,"eighty":-2.440257,"marketCap":28076220},{"date":"2022-08-26","current":-3.094918,"twenty":-5.661854,"median":-3.132245,"eighty":-2.440257,"marketCap":25996500},{"date":"2022-09-02","current":-2.902345,"twenty":-5.581809,"median":-3.128118,"eighty":-2.440257,"marketCap":24378940},{"date":"2022-09-09","current":-2.984876,"twenty":-5.560806,"median":-3.117013,"eighty":-2.440257,"marketCap":25072180},{"date":"2022-09-16","current":-2.668507,"twenty":-5.55316,"median":-3.10436,"eighty":-2.440257,"marketCap":22414760},{"date":"2022-09-23","current":-2.14581,"twenty":-5.519162,"median":-3.095823,"eighty":-2.439684,"marketCap":18024240},{"date":"2022-09-30","current":-2.379648,"twenty":-5.477266,"median":-3.088522,"eighty":-2.439647,"marketCap":19988420},{"date":"2022-10-07","current":-2.132055,"twenty":-5.456405,"median":-3.080603,"eighty":-2.439647,"marketCap":17908700},{"date":"2022-10-14","current":-2.502362,"twenty":-5.43594,"median":-3.072683,"eighty":-2.437394,"marketCap":20286302},{"date":"2022-10-21","current":-2.402267,"twenty":-5.421719,"median":-3.06696,"eighty":-2.434784,"marketCap":19474850},{"date":"2022-10-28","current":-2.359369,"twenty":-5.377446,"median":-3.06013,"eighty":-2.430342,"marketCap":19127085},{"date":"2022-11-04","current":-2.334363,"twenty":-5.363019,"median":-3.057014,"eighty":-2.4206,"marketCap":18924360},{"date":"2022-11-11","current":-2.477575,"twenty":-5.336338,"median":-3.043934,"eighty":-2.417533,"marketCap":20085364},{"date":"2022-11-18","current":-2.711681,"twenty":-5.332826,"median":-3.036058,"eighty":-2.417533,"marketCap":19156500},{"date":"2022-11-25","current":-2.760984,"twenty":-5.332826,"median":-3.034986,"eighty":-2.417533,"marketCap":19504800},{"date":"2022-12-02","current":-2.777419,"twenty":-5.332826,"median":-3.028333,"eighty":-2.417533,"marketCap":19620900},{"date":"2022-12-09","current":-2.39121,"twenty":-5.292381,"median":-3.026142,"eighty":-2.416192,"marketCap":16892550},{"date":"2022-12-16","current":-2.087173,"twenty":-5.292381,"median":-3.018926,"eighty":-2.406742,"marketCap":14744700},{"date":"2022-12-23","current":-1.972132,"twenty":-5.292381,"median":-3.00582,"eighty":-2.395506,"marketCap":13932000},{"date":"2022-12-30","current":-1.824222,"twenty":-5.292381,"median":-2.997432,"eighty":-2.389879,"marketCap":12887100},{"date":"2023-01-06","current":-2.202214,"twenty":-5.277173,"median":-2.989706,"eighty":-2.387968,"marketCap":15557400},{"date":"2023-01-13","current":-2.333853,"twenty":-5.260084,"median":-2.981981,"eighty":-2.376115,"marketCap":16487361},{"date":"2023-01-20","current":-2.30082,"twenty":-5.250996,"median":-2.973783,"eighty":-2.373517,"marketCap":16254000},{"date":"2023-01-27","current":-2.399427,"twenty":-5.240028,"median":-2.96653,"eighty":-2.370947,"marketCap":16950600},{"date":"2023-02-03","current":-2.284386,"twenty":-5.221675,"median":-2.956693,"eighty":-2.366583,"marketCap":16137900},{"date":"2023-02-10","current":-2.276169,"twenty":-5.202929,"median":-2.950137,"eighty":-2.360695,"marketCap":16079850},{"date":"2023-02-17","current":-2.44914,"twenty":-5.171998,"median":-2.943354,"eighty":-2.359369,"marketCap":16870750},{"date":"2023-02-24","current":-2.128219,"twenty":-5.154465,"median":-2.937326,"eighty":-2.348627,"marketCap":14660100},{"date":"2023-03-03","current":-2.330906,"twenty":-5.122989,"median":-2.92765,"eighty":-2.343232,"marketCap":16056300},{"date":"2023-03-10","current":-2.145109,"twenty":-5.087088,"median":-2.913716,"eighty":-2.342061,"marketCap":14776450},{"date":"2023-03-17","current":-2.195781,"twenty":-5.05618,"median":-2.905242,"eighty":-2.334159,"marketCap":15125500},{"date":"2023-03-24","current":-2.094437,"twenty":-5.017952,"median":-2.902345,"eighty":-2.329408,"marketCap":14427400},{"date":"2023-03-31","current":-1.97975,"twenty":-5.017055,"median":-2.891819,"eighty":-2.325041,"marketCap":13637383},{"date":"2023-04-06","current":-2.753172,"twenty":-5.017055,"median":-2.888698,"eighty":-2.322276,"marketCap":18965050},{"date":"2023-04-14","current":-1.993094,"twenty":-5.017952,"median":-2.874835,"eighty":-2.316037,"marketCap":13729300},{"date":"2023-04-21","current":-2.263344,"twenty":-5.002368,"median":-2.859591,"eighty":-2.313801,"marketCap":15590900},{"date":"2023-04-28","current":-2.280234,"twenty":-5.002368,"median":-2.849614,"eighty":-2.312786,"marketCap":15707250},{"date":"2023-05-05","current":-2.077547,"twenty":-5.002368,"median":-2.840873,"eighty":-2.302937,"marketCap":14311050},{"date":"2023-05-11","current":-2.043766,"twenty":-5.002368,"median":-2.835777,"eighty":-2.30082,"marketCap":14078350},{"date":"2023-05-19","current":-1.920317,"twenty":-5.002518,"median":-2.832097,"eighty":-2.294808,"marketCap":13055420},{"date":"2023-05-26","current":-1.887542,"twenty":-5.002667,"median":-2.817128,"eighty":-2.284962,"marketCap":12832600},{"date":"2023-06-02","current":-2.239311,"twenty":-5.002667,"median":-2.810544,"eighty":-2.283362,"marketCap":15224130},{"date":"2023-06-09","current":-1.973339,"twenty":-5.002817,"median":-2.806059,"eighty":-2.276679,"marketCap":13415900},{"date":"2023-06-16","current":-1.870383,"twenty":-5.008153,"median":-2.792391,"eighty":-2.269675,"marketCap":12715940},{"date":"2023-06-23","current":-1.921861,"twenty":-5.010821,"median":-2.779567,"eighty":-2.263344,"marketCap":13065920},{"date":"2023-06-30","current":-2.144934,"twenty":-5.017055,"median":-2.778549,"eighty":-2.263295,"marketCap":14582500},{"date":"2023-07-06","current":-2.024818,"twenty":-5.017952,"median":-2.777419,"eighty":-2.259272,"marketCap":13765880},{"date":"2023-07-14","current":-2.488124,"twenty":-5.020645,"median":-2.769833,"eighty":-2.254292,"marketCap":16915700},{"date":"2023-07-21","current":-2.745516,"twenty":-5.0361,"median":-2.767019,"eighty":-2.252684,"marketCap":18665600},{"date":"2023-07-27","current":-2.676878,"twenty":-5.039964,"median":-2.764793,"eighty":-2.252282,"marketCap":18198960},{"date":"2023-08-04","current":-2.453805,"twenty":-5.039964,"median":-2.753964,"eighty":-2.252129,"marketCap":16682380},{"date":"2023-08-11","current":-2.219738,"twenty":-5.039964,"median":-2.751307,"eighty":-2.246058,"marketCap":15091061},{"date":"2023-08-18","current":-2.21991,"twenty":-5.039964,"median":-2.751307,"eighty":-2.244476,"marketCap":15092230},{"date":"2023-08-25","current":-2.667127,"twenty":-5.039964,"median":-2.753168,"eighty":-2.251186,"marketCap":18132670},{"date":"2023-09-01","current":-2.495054,"twenty":-5.039964,"median":-2.751038,"eighty":-2.251186,"marketCap":16962820},{"date":"2023-09-08","current":-2.340189,"twenty":-5.039964,"median":-2.74376,"eighty":-2.251186,"marketCap":15909955},{"date":"2023-09-15","current":-2.288567,"twenty":-5.039964,"median":-2.738088,"eighty":-2.246453,"marketCap":15559001},{"date":"2023-09-22","current":-2.185324,"twenty":-5.039964,"median":-2.725967,"eighty":-2.236945,"marketCap":14857091},{"date":"2023-09-29","current":-2.426225,"twenty":-5.039964,"median":-2.723609,"eighty":-2.236573,"marketCap":16494880},{"date":"2023-10-06","current":-2.254153,"twenty":-5.039964,"median":-2.723609,"eighty":-2.234464,"marketCap":15325031},{"date":"2023-10-13","current":-2.013251,"twenty":-5.039964,"median":-2.723467,"eighty":-2.230216,"marketCap":13687241},{"date":"2023-10-20","current":-1.572776,"twenty":-5.039964,"median":-2.723467,"eighty":-2.222732,"marketCap":13507900},{"date":"2023-10-27","current":-1.600128,"twenty":-5.039964,"median":-2.72369,"eighty":-2.219772,"marketCap":13742820},{"date":"2023-11-03","current":-1.5591,"twenty":-5.039964,"median":-2.72369,"eighty":-2.211571,"marketCap":13390440},{"date":"2023-11-10","current":-1.463365,"twenty":-5.039964,"median":-2.718749,"eighty":-2.202243,"marketCap":12568220},{"date":"2023-11-17","current":-1.487026,"twenty":-5.039964,"median":-2.715489,"eighty":-2.195907,"marketCap":13363424},{"date":"2023-11-24","current":-1.359275,"twenty":-5.039964,"median":-2.713071,"eighty":-2.189723,"marketCap":12215368},{"date":"2023-12-01","current":-1.503045,"twenty":-5.039964,"median":-2.709773,"eighty":-2.185324,"marketCap":13507379},{"date":"2023-12-08","current":-1.50958,"twenty":-5.039964,"median":-2.70214,"eighty":-2.168223,"marketCap":13566106},{"date":"2023-12-15","current":-1.489975,"twenty":-5.039964,"median":-2.696474,"eighty":-2.162,"marketCap":13389923},{"date":"2023-12-22","current":-1.385415,"twenty":-5.039964,"median":-2.696474,"eighty":-2.156514,"marketCap":12450279},{"date":"2023-12-29","current":-1.398485,"twenty":-5.039964,"median":-2.696931,"eighty":-2.156278,"marketCap":12567735},{"date":"2024-01-05","current":-1.424625,"twenty":-5.039964,"median":-2.698293,"eighty":-2.150909,"marketCap":12802646},{"date":"2024-01-12","current":-1.353525,"twenty":-5.039964,"median":-2.698293,"eighty":-2.145109,"marketCap":12163688},{"date":"2024-01-19","current":-1.359275,"twenty":-5.043083,"median":-2.699655,"eighty":-2.135592,"marketCap":12215368},{"date":"2024-01-26","current":-1.385415,"twenty":-5.039964,"median":-2.698293,"eighty":-2.120042,"marketCap":12450279},{"date":"2024-02-02","current":-1.476905,"twenty":-5.039964,"median":-2.698293,"eighty":-2.111328,"marketCap":13272468},{"date":"2024-02-09","current":-1.516115,"twenty":-5.039964,"median":-2.687524,"eighty":-2.094437,"marketCap":13624834},{"date":"2024-02-16","current":-1.498107,"twenty":-5.039964,"median":-2.682084,"eighty":-2.081184,"marketCap":14017010},{"date":"2024-02-23","current":-1.59882,"twenty":-5.039964,"median":-2.676392,"eighty":-2.064581,"marketCap":14959330},{"date":"2024-03-01","current":-1.699533,"twenty":-5.0361,"median":-2.668507,"eighty":-2.049674,"marketCap":15901650},{"date":"2024-03-08","current":-1.422572,"twenty":-5.0361,"median":-2.666881,"eighty":-2.03312,"marketCap":13310270},{"date":"2024-03-15","current":-1.472929,"twenty":-5.0361,"median":-2.656354,"eighty":-2.014962,"marketCap":13781430},{"date":"2024-03-22","current":-1.435162,"twenty":-5.0361,"median":-2.651857,"eighty":-1.997134,"marketCap":13428060},{"date":"2024-03-28","current":-1.422572,"twenty":-5.0361,"median":-2.646899,"eighty":-1.988953,"marketCap":13310270},{"date":"2024-04-05","current":-1.724712,"twenty":-5.039964,"median":-2.645782,"eighty":-1.976203,"marketCap":16137230},{"date":"2024-04-12","current":-1.59882,"twenty":-5.039964,"median":-2.640997,"eighty":-1.967997,"marketCap":14959330},{"date":"2024-04-19","current":-1.479223,"twenty":-5.039964,"median":-2.636576,"eighty":-1.942422,"marketCap":13840325},{"date":"2024-04-26","current":-1.397394,"twenty":-5.0361,"median":-2.625126,"eighty":-1.921861,"marketCap":13074690},{"date":"2024-05-03","current":-1.510696,"twenty":-5.0361,"median":-2.62043,"eighty":-1.908491,"marketCap":14134800},{"date":"2024-05-10","current":-2.303812,"twenty":-5.0361,"median":-2.62043,"eighty":-1.904702,"marketCap":21555570},{"date":"2024-05-17","current":-2.762595,"twenty":-5.0361,"median":-2.63632,"eighty":-1.904702,"marketCap":26267170},{"date":"2024-05-24","current":-2.762595,"twenty":-5.0361,"median":-2.640997,"eighty":-1.904702,"marketCap":26267170},{"date":"2024-05-31","current":-3.010361,"twenty":-5.0361,"median":-2.645943,"eighty":-1.904702,"marketCap":28622970},{"date":"2024-06-07","current":-3.282904,"twenty":-5.0361,"median":-2.651857,"eighty":-1.904702,"marketCap":31214350},{"date":"2024-06-14","current":-3.205683,"twenty":-5.039964,"median":-2.663299,"eighty":-1.904702,"marketCap":30480120},{"date":"2024-06-21","current":-2.522301,"twenty":-5.039964,"median":-2.666881,"eighty":-1.904582,"marketCap":23982420},{"date":"2024-06-28","current":-2.149547,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20438220},{"date":"2024-07-05","current":-2.186822,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20792640},{"date":"2024-07-12","current":-2.236523,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":21265200},{"date":"2024-07-15","current":-2.161972,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20556360},{"date":"2024-08-02","current":-2.609277,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":24809400},{"date":"2024-08-09","current":-2.360774,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":22446600},{"date":"2024-08-16","current":-2.360774,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":22446600},{"date":"2024-08-23","current":-2.286223,"twenty":-5.05618,"median":-2.675731,"eighty":-1.887542,"marketCap":21737760},{"date":"2024-08-30","current":-2.335924,"twenty":-5.05618,"median":-2.675731,"eighty":-1.890067,"marketCap":22210320},{"date":"2024-09-06","current":-2.224098,"twenty":-5.05618,"median":-2.675731,"eighty":-1.890067,"marketCap":21147060},{"date":"2024-09-13","current":-2.087421,"twenty":-5.05618,"median":-2.675731,"eighty":-1.899521,"marketCap":19847520},{"date":"2024-09-20","current":-1.96317,"twenty":-5.05618,"median":-2.675731,"eighty":-1.917578,"marketCap":18666120},{"date":"2024-09-27","current":-1.764368,"twenty":-5.05618,"median":-2.675731,"eighty":-1.921243,"marketCap":16775880},{"date":"2024-10-04","current":-2.008373,"twenty":-5.05618,"median":-2.675731,"eighty":-1.947416,"marketCap":16657740},{"date":"2024-10-11","current":-1.951398,"twenty":-5.05618,"median":-2.675731,"eighty":-1.961627,"marketCap":16185180},{"date":"2024-10-18","current":-2.122323,"twenty":-5.05618,"median":-2.675731,"eighty":-1.972856,"marketCap":17602860},{"date":"2024-10-25","current":-2.122323,"twenty":-5.05618,"median":-2.675731,"eighty":-1.978331,"marketCap":17602860},{"date":"2024-10-31","current":-1.937154,"twenty":-5.05618,"median":-2.675731,"eighty":-1.988348,"marketCap":16067040},{"date":"2024-11-08","current":-2.122323,"twenty":-5.05618,"median":-2.675818,"eighty":-2.003331,"marketCap":17602860},{"date":"2024-11-15","current":-1.908667,"twenty":-5.05618,"median":-2.675818,"eighty":-2.007658,"marketCap":15830760},{"date":"2024-11-22","current":-1.599829,"twenty":-5.05618,"median":-2.675818,"eighty":-2.007658,"marketCap":15121920},{"date":"2024-11-29","current":-2.06427,"twenty":-5.05618,"median":-2.675818,"eighty":-2.022617,"marketCap":19511920},{"date":"2024-12-06","current":-2.216055,"twenty":-5.05618,"median":-2.675818,"eighty":-2.028308,"marketCap":20946620},{"date":"2024-12-13","current":-2.231234,"twenty":-5.05618,"median":-2.675818,"eighty":-2.043766,"marketCap":21090090},{"date":"2024-12-20","current":-2.200877,"twenty":-5.05618,"median":-2.675818,"eighty":-2.051201,"marketCap":20803150},{"date":"2024-12-27","current":-2.291947,"twenty":-5.05618,"median":-2.675818,"eighty":-2.063251,"marketCap":21663970},{"date":"2025-01-03","current":-2.155341,"twenty":-5.05618,"median":-2.675818,"eighty":-2.067504,"marketCap":20372740},{"date":"2025-01-10","current":-2.109806,"twenty":-5.05618,"median":-2.675905,"eighty":-2.079813,"marketCap":19942330},{"date":"2025-01-17","current":-1.821415,"twenty":-5.05618,"median":-2.675905,"eighty":-2.079813,"marketCap":17216400},{"date":"2025-01-24","current":-1.699987,"twenty":-5.05618,"median":-2.675731,"eighty":-2.077956,"marketCap":16068640},{"date":"2025-01-31","current":-1.624095,"twenty":-5.019747,"median":-2.668507,"eighty":-2.064332,"marketCap":15351290},{"date":"2025-02-07","current":-1.86695,"twenty":-4.974978,"median":-2.666881,"eighty":-2.051347,"marketCap":17646810},{"date":"2025-02-14","current":-1.958021,"twenty":-4.948211,"median":-2.651857,"eighty":-2.049178,"marketCap":18507630},{"date":"2025-02-21","current":-2.42188,"twenty":-4.923399,"median":-2.645943,"eighty":-2.049178,"marketCap":22680335},{"date":"2025-02-28","current":-2.238151,"twenty":-4.869408,"median":-2.636832,"eighty":-2.049178,"marketCap":20959758},{"date":"2025-03-07","current":-2.204746,"twenty":-4.859238,"median":-2.619088,"eighty":-2.043766,"marketCap":20646926},{"date":"2025-03-14","current":-2.021017,"twenty":-4.814317,"median":-2.611175,"eighty":-2.043766,"marketCap":18926349},{"date":"2025-03-21","current":-2.204746,"twenty":-4.762681,"median":-2.603257,"eighty":-2.043766,"marketCap":20646926},{"date":"2025-03-28","current":-2.021017,"twenty":-4.736,"median":-2.593961,"eighty":-2.037721,"marketCap":18926349},{"date":"2025-04-04","current":-1.904099,"twenty":-4.695977,"median":-2.574477,"eighty":-2.024878,"marketCap":17831436},{"date":"2025-04-11","current":-1.78718,"twenty":-4.601221,"median":-2.559576,"eighty":-2.021017,"marketCap":16736523},{"date":"2025-04-17","current":-2.338367,"twenty":-4.561033,"median":-2.554258,"eighty":-2.021017,"marketCap":21898255},{"date":"2025-04-25","current":-2.254854,"twenty":-4.395718,"median":-2.539152,"eighty":-2.021017,"marketCap":21116174},{"date":"2025-05-02","current":-2.221448,"twenty":-4.236599,"median":-2.517715,"eighty":-2.021017,"marketCap":20803342},{"date":"2025-05-09","current":-2.355069,"twenty":-4.022387,"median":-2.509122,"eighty":-2.021017,"marketCap":22054671},{"date":"2025-05-16","current":-2.188043,"twenty":-3.94774,"median":-2.501973,"eighty":-2.021017,"marketCap":20490510},{"date":"2025-05-23","current":-2.379913,"twenty":-3.876119,"median":-2.498632,"eighty":-2.021017,"marketCap":23149584},{"date":"2025-05-30","current":-2.524637,"twenty":-3.823943,"median":-2.498632,"eighty":-2.021017,"marketCap":24557329},{"date":"2025-06-06","current":-2.395993,"twenty":-3.78622,"median":-2.493989,"eighty":-2.021017,"marketCap":23306000},{"date":"2025-06-13","current":-2.494967,"twenty":-3.754515,"median":-2.493989,"eighty":-2.021017,"marketCap":24268720},{"date":"2025-06-20","current":-2.214076,"twenty":-3.676342,"median":-2.479073,"eighty":-2.020561,"marketCap":21536480},{"date":"2025-06-27","current":-2.032324,"twenty":-3.636238,"median":-2.464048,"eighty":-2.020561,"marketCap":19768560},{"date":"2025-07-03","current":-2.280168,"twenty":-3.554341,"median":-2.459464,"eighty":-2.020561,"marketCap":22179360},{"date":"2025-07-11","current":-2.329737,"twenty":-3.48487,"median":-2.44873,"eighty":-2.020561,"marketCap":22661520},{"date":"2025-07-18","current":-2.709765,"twenty":-3.426034,"median":-2.448382,"eighty":-2.020561,"marketCap":26358080},{"date":"2025-07-25","current":-2.825426,"twenty":-3.389044,"median":-2.448382,"eighty":-2.020561,"marketCap":27483120},{"date":"2025-08-01","current":-2.676719,"twenty":-3.365641,"median":-2.448382,"eighty":-2.020561,"marketCap":26036640},{"date":"2025-08-08","current":-2.610627,"twenty":-3.332199,"median":-2.448382,"eighty":-2.020561,"marketCap":25393760},{"date":"2025-08-15","current":-2.428875,"twenty":-3.310157,"median":-2.445165,"eighty":-2.020561,"marketCap":23625840},{"date":"2025-08-22","current":-2.263645,"twenty":-3.264565,"median":-2.436645,"eighty":-2.020561,"marketCap":22018640},{"date":"2025-08-29","current":-2.337999,"twenty":-3.264565,"median":-2.434612,"eighty":-2.020561,"marketCap":22741880},{"date":"2025-09-05","current":-2.271907,"twenty":-3.248873,"median":-2.421397,"eighty":-2.020104,"marketCap":22099000},{"date":"2025-09-12","current":-2.362783,"twenty":-3.247549,"median":-2.416566,"eighty":-2.020561,"marketCap":22982960},{"date":"2025-09-19","current":-2.34626,"twenty":-3.208752,"median":-2.407158,"eighty":-2.020561,"marketCap":22822240},{"date":"2025-09-26","current":-2.313214,"twenty":-3.208752,"median":-2.402267,"eighty":-2.020561,"marketCap":22500800},{"date":"2025-10-03","current":-2.63298,"twenty":-3.208752,"median":-2.395993,"eighty":-2.020561,"marketCap":24926330},{"date":"2025-10-10","current":-2.623774,"twenty":-3.208752,"median":-2.395993,"eighty":-2.020561,"marketCap":24839175},{"date":"2025-10-17","current":-2.669805,"twenty":-3.208752,"median":-2.395993,"eighty":-2.020561,"marketCap":25274950},{"date":"2025-10-24","current":-2.636294,"twenty":-3.208752,"median":-2.395993,"eighty":-2.020561,"marketCap":24957705},{"date":"2025-10-31","current":-3.130116,"twenty":-3.221382,"median":-2.395993,"eighty":-2.020561,"marketCap":29632700},{"date":"2025-11-07","current":-3.498365,"twenty":-3.252844,"median":-2.395993,"eighty":-2.020561,"marketCap":33118900},{"date":"2025-11-14","current":-2.766604,"twenty":-3.254271,"median":-2.395993,"eighty":-2.020561,"marketCap":26191350},{"date":"2025-11-21","current":-2.960813,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":24057240},{"date":"2025-11-28","current":-2.702248,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":21956340},{"date":"2025-12-05","current":-2.702248,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":21956340},{"date":"2025-12-12","current":-2.879445,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":23396100},{"date":"2025-12-19","current":-2.680098,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":21776370},{"date":"2025-12-26","current":-2.859745,"twenty":-3.283821,"median":-2.395993,"eighty":-2.020561,"marketCap":23236034},{"date":"2026-01-02","current":-2.715556,"twenty":-3.283821,"median":-2.402326,"eighty":-2.020561,"marketCap":22064469},{"date":"2026-01-09","current":-3.211953,"twenty":-3.28831,"median":-2.407158,"eighty":-2.020561,"marketCap":26097799},{"date":"2026-01-16","current":-2.999592,"twenty":-3.28831,"median":-2.407158,"eighty":-2.020561,"marketCap":24372324},{"date":"2026-01-23","current":-3.052682,"twenty":-3.283821,"median":-2.407158,"eighty":-2.020561,"marketCap":24803693},{"date":"2026-01-30","current":-2.654506,"twenty":-3.264565,"median":-2.407158,"eighty":-2.020561,"marketCap":21568429},{"date":"2026-02-06","current":-2.25633,"twenty":-3.241125,"median":-2.403874,"eighty":-2.020561,"marketCap":18333164}],"updateTime":1770469858565},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NNVC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608864604","title":"NanoViricides President Unveils Breakthrough Antiviral Technology in Mission Matters Interview","url":"https://stock-news.laohu8.com/highlight/detail?id=2608864604","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608864604?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:32","pubTimestamp":1770039135,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via ACCESS Newswire  on February 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL5tFBQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4568","BK4139"],"gpt_icon":0},{"id":"2604113263","title":"NanoViricides Inc. to Present at DealFlow Discovery Conference in Atlantic City","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113263","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113263?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:01","pubTimestamp":1768914064,"startTime":"0","endTime":"0","summary":"NanoViricides Inc., a clinical stage company developing broad-spectrum antiviral drugs, will participate in the 3rd Annual DealFlow Discovery Conference on January 28th and 29th, 2026. The event will be held at The Borgata Hotel, Casino & Spa in Atlantic City, NJ. Company President and Executive Chairman, Dr. Anil R. Diwan, is scheduled to deliver a presentation on Thursday, January 29th at 11:00 am ET and will be available for one-on-one investor meetings throughout the conference. Investors can request a pass to attend by registering on the conference website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via ACCESS Newswire  on January 20, 2026, and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL3kWJCd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","NNVC"],"gpt_icon":0},{"id":"2603568254","title":"NanoViricides Reports NV-387 Outperforms Tamiflu and Xofluza Against H3N2 in Animal Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2603568254","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603568254?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:31","pubTimestamp":1768311066,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. has announced promising research results for its broad-spectrum antiviral drug candidate, NV-387. The company reports that NV-387 has demonstrated substantial superiority over existing treatments like Tamiflu and Xofluza in animal models of Influenza A/H3N2 lethal lung infection. NV-387 is also active against coronaviruses, RSV, and other viruses that use heparan sulfate features to infect human cells. The company emphasizes that NV-387’s unique mechanism makes it difficult for viruses to develop resistance, addressing a major limitation of current antiviral therapies. These findings highlight NV-387’s potential as a future dominant player in the treatment of acute and severe acute respiratory infections. The timeline for the presentation of these results has not been specified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated conte","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nNDL1bCYq6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","NNVC"],"gpt_icon":0},{"id":"2591981556","title":"NanoViricides Inc (Pre-Reincorporation) : Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2591981556","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591981556?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:18","pubTimestamp":1765887509,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XM0G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4568","NNVC"],"gpt_icon":0},{"id":"2588778641","title":"BRIEF-anoViricides Signs Agreement for Orphan Drug Strategy of NV-387 for Mpox, Smallpox, and Measles","url":"https://stock-news.laohu8.com/highlight/detail?id=2588778641","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588778641?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:33","pubTimestamp":1764595986,"startTime":"0","endTime":"0","summary":"BRIEF-anoViricides Signs Agreement for Orphan Drug Strategy of NV-387 for Mpox, Smallpox, and MeaslesDec 1 (Reuters) - NanoViricides, Inc NNVC.A:NANOVIRICIDES: SIGNED MASTER SERVICES AGREEMENT WITH ON","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","NNVC"],"gpt_icon":0},{"id":"2588777854","title":"NanoViricides: Signed Master Services Agreement With Only Orphans Cote for Orphan Drug Strategy of Nv-387 for Treatment of Mpox, Smallpox, & Measles","url":"https://stock-news.laohu8.com/highlight/detail?id=2588777854","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588777854?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:31","pubTimestamp":1764595910,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2588778687","title":"NanoViricides Signs Master Services Agreement with Only Orphans Cote for Orphan Drug Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2588778687","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588778687?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:30","pubTimestamp":1764595859,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. announced that it has signed a Master Services Agreement with Only Orphans Cote, LLC, a regulatory consulting firm. Under this agreement, Only Orphans Cote will assist NanoViricides in developing its orphan drug strategy for the antiviral drug candidate NV-387, as well as preparing and prosecuting relevant orphan drug designation applications with the US FDA Office of Orphan Products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via ACCESS Newswire  on December 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL9kfm4G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2028103732.USD","BK4139","BK5061","NNVC","LU1481600234.SGD","LU0158827948.USD","LU1923622291.USD","LU1196032939.SGD","BK4568","LU2271345857.HKD","LU1273509221.SGD","LU2125909916.SGD","RTO.UK","LU0158827781.USD","LU2089283258.USD","LU2023251221.USD","LU2111349929.HKD","LU1481599808.USD","LU1487256676.USD","LU2125909759.SGD","LU2089284900.SGD"],"gpt_icon":0},{"id":"2586293497","title":"NanoViricides Holds 2025 Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586293497","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586293497?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:04","pubTimestamp":1764194663,"startTime":"0","endTime":"0","summary":"NanoViricides ( ($NNVC) ) has provided an announcement. On November 22, 2025, NanoViricides, Inc. held its 2025 Annual Meeting of Stockholders, whe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanoviricides-holds-2025-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanoviricides-holds-2025-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2586298633","title":"NanoViricides Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586298633","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586298633?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:32","pubTimestamp":1764192720,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. held its annual meeting of stockholders on November 22, 2025. Shareholders approved the re-election of Anil Diwan as a director. The advisory vote on executive compensation was also approved. In addition, the appointment of EisnerAmper, LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026 was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL223qg4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2584262914","title":"NanoViricides reports Q3 EPS (10c) vs. (23c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2584262914","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584262914?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:55","pubTimestamp":1763387734,"startTime":"0","endTime":"0","summary":"The company said, “During the current quarter, we have diligently continued our progress towards initiating a Phase II human safety and effectivene...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-reports-q3-eps-10c-vs-23c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-reports-q3-eps-10c-vs-23c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNVC"],"gpt_icon":0},{"id":"2583468768","title":"NanoViricides Secures $6 Million Through Securities Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2583468768","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583468768?lang=en_us&edition=fundamental","pubTime":"2025-11-15 06:13","pubTimestamp":1763158390,"startTime":"0","endTime":"0","summary":"An update from NanoViricides ( ($NNVC) ) is now available. On November 10, 2025, NanoViricides, Inc. entered into a securities purchase agreement w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanoviricides-secures-6-million-through-securities-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanoviricides-secures-6-million-through-securities-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4568","NNVC"],"gpt_icon":0},{"id":"2583682954","title":"NanoViricides Launches Private Placement of Warrants in $6 Million Funding Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2583682954","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583682954?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:46","pubTimestamp":1763156776,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. has announced a private placement in connection with its recent $6 million registered direct offering. As part of the transaction, the company will issue Series A and Series B warrants to purchase up to 3,571,429 shares of common stock each to a single healthcare institutional investor. The Series A Warrants have an exercise price of $1.75 per share and will be exercisable six months after issuance, expiring two years later. The Series B Warrants have an exercise price of $2.00 per share, also exercisable after six months, and will expire 5.5 years from the issuance date. These warrants and the underlying shares are being offered in reliance on an exemption from SEC registration requirements and are not registered under the Securities Act.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL13MznN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2583509427","title":"NanoViricides Presents Drug Pipeline at Pharma Partnering Summit 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2583509427","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583509427?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:30","pubTimestamp":1763127041,"startTime":"0","endTime":"0","summary":"NanoViricides Inc., a clinical-stage leader in broad-spectrum antiviral drug development, presented at the Pharma Partnering Summit 2025 held at the Hilton Boston Logan Airport in Boston, MA. The presentation, delivered by President and Executive Chairman Dr. Anil R. Diwan, provided updates on the company's drug pipeline and platform technologies available for licensing, highlighting the Phase II clinical-stage antiviral NV-387 and additional drug candidates targeting herpesviruses and HIV.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via ACCESS Newswire  on November 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL6v8vFg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"2582628953","title":"NanoViricides prices 3.57M shares at $1.68 in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2582628953","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582628953?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:45","pubTimestamp":1762868742,"startTime":"0","endTime":"0","summary":"NanoViricides (NNVC) entered into a securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,57...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-prices-3-57m-shares-at-1-68-in-registered-direct-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-prices-3-57m-shares-at-1-68-in-registered-direct-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2582361006","title":"NanoViricides Inc. Launches Private Placement of Warrants in $6 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2582361006","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582361006?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:30","pubTimestamp":1762867825,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. has announced a concurrent private placement alongside its registered direct offering, issuing Series A and Series B warrants to purchase up to 3,571,429 shares of common stock each. The Series A Warrants will have an exercise price of $1.75 per share, exercisable six months after issuance and expiring two years later. The Series B Warrants, with an exercise price of $2.00 per share-about a 20% premium to the prior closing price-become exercisable after six months and expire 5.5 years from issuance. The warrants and the shares underlying them will be sold to an institutional investor in a transaction exempt from SEC registration requirements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL4BNpyr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2582877275","title":"NanoViricides receives approval to start Phase II trial of NV-387","url":"https://stock-news.laohu8.com/highlight/detail?id=2582877275","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582877275?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:20","pubTimestamp":1762784458,"startTime":"0","endTime":"0","summary":"NanoViricides (NNVC) has received approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-receives-approval-to-start-phase-ii-trial-of-nv-387-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-receives-approval-to-start-phase-ii-trial-of-nv-387-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2582091871","title":"NanoViricides Wins DRC Approval to Begin Phase II Trial of NV-387 for MPox","url":"https://stock-news.laohu8.com/highlight/detail?id=2582091871","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582091871?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:31","pubTimestamp":1762781484,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. has received approval from the regulatory agency ACOREP of the Democratic Republic of Congo  to begin a Phase II clinical trial of its antiviral drug candidate, NV-387, for the treatment of MPox. This follows earlier clearance from the DRC's national Ethics Committee, CNES, in May 2025. The company is finalizing and translating the required documentation for submission, after which patient recruitment for the trial can commence. No grant or funding from multiple organizations was announced in this update.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via ACCESS Newswire  on November 10, 2025, and is solely responsible for the informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL1Vl1g6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2580215297","title":"NanoViricides Inc. to Present at Spartan Capital Investor Conference in New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2580215297","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580215297?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176642,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. will present at the Spartan Capital Investor Conference 2025 in New York City on Monday, November 3, 2025. The company will provide an update on its drug pipeline and platform technologies, including NV-387, a broad-spectrum antiviral drug currently in Phase II clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoViricides Inc. published the original content used to generate this news brief via ACCESS Newswire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDLpQS61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"2579906893","title":"NanoViricides Announces NV-387 Shows Potent Anti-Measles Activity in Phase I Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2579906893","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579906893?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:45","pubTimestamp":1761741919,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. has announced significant progress with its clinical lead drug, NV-387, which has demonstrated potent activity against the Measles virus in both cell culture studies and a humanized animal model. Results from preclinical studies showed that NV-387 treatment extended survival in a lethal Measles infection model by 130%, from 7.4 days in untreated animals to 17 days in treated ones. NV-387 has also completed Phase I human trials, with no reportable adverse events, confirming its safety and tolerability in healthy subjects. The company is now positioned to support emergency use applications of NV-387 for Measles patients under FDA guidelines and is open to Physician's Investigator-Initiated INDs for urgent cases. NV-387 is formulated as oral gummies, offering a potential advantage for patients with Measles-related throat irritation. The drug is also advancing into a Phase II clinical trial for the evaluation of safety and effectiveness in treating MPox. These results ha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDLb6GjyC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2577936256","title":"NanoViricides Reports Strong Antiviral Activity for NV-387 Against Measles in Preclinical Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2577936256","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577936256?lang=en_us&edition=fundamental","pubTime":"2025-10-22 20:45","pubTimestamp":1761137122,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. announced that its clinical lead drug, NV-387, has demonstrated strong antiviral activity against the Measles virus in both cell culture studies and a humanized animal model. The company reported that NV-387 treatment led to protection of lung tissue, an important outcome for patients with severe viral infections. According to NanoViricides, NV-387 has completed a Phase I clinical trial in healthy subjects, showing no reportable adverse events and was found to be safe and well tolerated. The company highlighted that NV-387 is a multi-purpose, broad-spectrum antiviral currently being developed for several respiratory viral infections, including RSV, Influenza, Bird Flu H5N1, Coronaviruses, COVID-19, MPox, and Smallpox. Results from the studies have already been presented. NanoViricides is seeking additional funding to support further development of NV-387 as a treatment for Measles.Disclaimer: This news brief was created by Public Technologies  using generative artifi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDL8lDxP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","NNVC"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}